Melvin Spigelman
Director/Board Member at AN2 THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Melvin Spigelman active positions
Companies | Position | Start | End |
---|---|---|---|
AN2 THERAPEUTICS, INC. | Director/Board Member | 2022-01-31 | - |
Independent Dir/Board Member | 2022-01-31 | - | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Director/Board Member | 2003-05-31 | - |
Chief Executive Officer | 2008-12-31 | - | |
President | 2008-12-31 | - | |
Chief Tech/Sci/R&D Officer | 2003-05-31 | 2008-12-31 | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Private Equity Investor | 2004-12-31 | - |
Tres Cantos Open Lab Foundation
Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Director/Board Member | - | - |
Career history of Melvin Spigelman
Former positions of Melvin Spigelman
Companies | Position | Start | End |
---|---|---|---|
SYNERGY PHARMACEUTICALS INC | Director/Board Member | 2008-08-20 | 2018-10-30 |
Chairman | 2018-10-30 | 2019-04-30 | |
Independent Dir/Board Member | 2008-08-20 | 2018-10-30 | |
THE MEDICINES COMPANY | Director/Board Member | 2005-09-26 | 2017-12-31 |
Independent Dir/Board Member | 2005-09-26 | 2017-12-31 | |
Hudson-Douglas Ltd. | President | - | 2003-05-31 |
ABBOTT INDIA LIMITED | Chief Tech/Sci/R&D Officer | 1991-12-31 | 1999-12-31 |
Corporate Officer/Principal | 1999-12-31 | 2000-12-31 | |
Knoll Pharmaceutical Co. | Chief Tech/Sci/R&D Officer | 1991-12-31 | 1999-12-31 |
Corporate Officer/Principal | 1999-12-31 | 2000-12-31 | |
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Melvin Spigelman
Brown University | Undergraduate Degree |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Statistics
International
United States | 9 |
India | 2 |
Germany | 2 |
Operational
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Independent Dir/Board Member | 3 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ABBOTT INDIA LIMITED | Health Technology |
AN2 THERAPEUTICS, INC. | Health Technology |
Private companies | 7 |
---|---|
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Hudson-Douglas Ltd. | |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Finance |
Tres Cantos Open Lab Foundation
Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Commercial Services |
Knoll Pharmaceutical Co. |
- Stock Market
- Insiders
- Melvin Spigelman
- Experience